Dr. Richard Furman Describes Diffuse Large B-Cell Lymphoma Treatment Regimens

In this Onc Live video, Dr. Richard Furman, Director of the CLL Research Center describes the chemotherapy regimens available to patients with diffuse large B-cell lymphoma. (DLBCL)

A list of DLBCL trials at Weill Cornell Medicine is available on the Joint Clinical Trials website.

Unknown's avatar

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment